{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:48:00Z","timestamp":1792273680776,"version":"4.4.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474534"],"award-info":[{"award-number":["82474534"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["25Y12800800"],"award-info":[{"award-number":["25Y12800800"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00198-026-08059-6","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T21:55:26Z","timestamp":1777413326000},"page":"1915-1927","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Osteoporosis in rheumatoid arthritis: a new perspective on risk factors and clinical prediction models"],"prefix":"10.1007","volume":"37","author":[{"given":"Yubo","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiaoYu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8797-7778","authenticated-orcid":false,"given":"Qianqian","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"8059_CR1","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/S0140-6736(23)01525-8","volume":"402","author":"A Di Matteo","year":"2023","unstructured":"Di Matteo A, Bathon JM, Emery P (2023) Rheumatoid arthritis. Lancet 402:2019\u20132033","journal-title":"Lancet"},{"key":"8059_CR2","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41584-022-00827-y","volume":"18","author":"A Finckh","year":"2022","unstructured":"Finckh A, Gilbert B, Hodkinson B, Bae SC, Thomas R, Deane KD, Alpizar-Rodriguez D, Lauper K (2022) Global epidemiology of rheumatoid arthritis. Nat Rev Rheumatol 18:591\u2013602","journal-title":"Nat Rev Rheumatol"},{"key":"8059_CR3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41584-022-00764-w","volume":"18","author":"B So\u00f3s","year":"2022","unstructured":"So\u00f3s B, Szentp\u00e9tery \u00c1, Raterman HG, Lems WF, Bhattoa HP, Szekanecz Z (2022) Effects of targeted therapies on bone in rheumatic and musculoskeletal diseases. Nat Rev Rheumatol 18:249\u2013257","journal-title":"Nat Rev Rheumatol"},{"key":"8059_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cells11101609","author":"E Schwendich","year":"2022","unstructured":"Schwendich E, Salinas Tejedor L, Schmitz G et al (2022) Modulation of dopamine receptors on osteoblasts as a possible therapeutic strategy for inducing bone formation in arthritis. Cells. https:\/\/doi.org\/10.3390\/cells11101609","journal-title":"Cells"},{"key":"8059_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14041138","author":"T Miyamoto","year":"2025","unstructured":"Miyamoto T (2025) Osteoporosis and rheumatoid arthritis: mechanisms underlying osteoclast differentiation and activation or factors associated with hip fractures. J Clin Med. https:\/\/doi.org\/10.3390\/jcm14041138","journal-title":"J Clin Med"},{"key":"8059_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.962969","volume":"9","author":"R Sakthiswary","year":"2022","unstructured":"Sakthiswary R, Uma Veshaaliini R, Chin KY, Das S, Sirasanagandla SR (2022) Pathomechanisms of bone loss in rheumatoid arthritis. Front Med (Lausanne) 9:962969","journal-title":"Front Med (Lausanne)"},{"key":"8059_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00198-024-07311-1","volume":"36","author":"O Taylor-Williams","year":"2025","unstructured":"Taylor-Williams O, Keen H, Preen DB, Nossent J, Inderjeeth CA (2025) First fracture in rheumatoid arthritis: analysis by fracture site, gender, age, and comorbidities. Osteoporos Int 36:113\u2013121","journal-title":"Osteoporos Int"},{"key":"8059_CR8","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1093\/rheumatology\/kead579","volume":"63","author":"K Sonomoto","year":"2024","unstructured":"Sonomoto K, Nakayamada S, Fujino Y et al (2024) Biological\/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a multicenter prospective observational study. Rheumatology (Oxford) 63:2239\u20132248","journal-title":"Rheumatology (Oxford)"},{"key":"8059_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-025-01598-8","author":"T Furuya","year":"2025","unstructured":"Furuya T, Inoue E, Yamanaka H, Harigai M, Tanaka E (2025) Increasing fracture incidence over 13\u00a0years in patients with rheumatoid arthritis from the IORRA cohort. J Bone Miner Metab. https:\/\/doi.org\/10.1007\/s00774-025-01598-8","journal-title":"J Bone Miner Metab"},{"key":"8059_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/imj.70065","author":"A Lyon","year":"2025","unstructured":"Lyon A, Lester S, Stanhope J et al (2025) Dual-energy X-ray absorptiometry and anti-osteoporotic medication use in Australian patients with early rheumatoid arthritis using data from the Australian Rheumatology Association Database. Intern Med J. https:\/\/doi.org\/10.1111\/imj.70065","journal-title":"Intern Med J"},{"key":"8059_CR11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.46497\/ArchRheumatol.2024.10171","volume":"39","author":"\u00d6 Tomay Aksoy","year":"2024","unstructured":"Tomay Aksoy \u00d6, Kutluk \u00d6, Sezer \u0130 (2024) Osteoporosis knowledge and awareness among rheumatoid arthritis patients: a cross-sectional controlled study. Arch Rheumatol 39:411\u2013418","journal-title":"Arch Rheumatol"},{"key":"8059_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078276","volume":"386","author":"O Efthimiou","year":"2024","unstructured":"Efthimiou O, Seo M, Chalkou K, Debray T, Egger M, Salanti G (2024) Developing clinical prediction models: a step-by-step guide. BMJ 386:e078276","journal-title":"BMJ"},{"key":"8059_CR13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13075-023-03140-5","volume":"25","author":"Y Shao","year":"2023","unstructured":"Shao Y, Zhang H, Shi Q, Wang Y, Liang Q (2023) Clinical prediction models of rheumatoid arthritis and its complications: focus on cardiovascular disease and interstitial lung disease. Arthrit Res Ther 25:159","journal-title":"Arthrit Res Ther"},{"key":"8059_CR14","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/BOR.0000000000000267","volume":"28","author":"M Dougados","year":"2016","unstructured":"Dougados M (2016) Comorbidities in rheumatoid arthritis. Curr Opin Rheumatol 28:282\u2013288","journal-title":"Curr Opin Rheumatol"},{"key":"8059_CR15","doi-asserted-by":"crossref","unstructured":"Kanis JA, Melton LJ, 3rd, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9:1137\u20131141","DOI":"10.1002\/jbmr.5650090802"},{"key":"8059_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-20016-x","volume":"12","author":"S Moshayedi","year":"2022","unstructured":"Moshayedi S, Tasorian B, Almasi-Hashiani A (2022) The prevalence of osteoporosis in rheumatoid arthritis patient: a systematic review and meta-analysis. Sci Rep 12:15844","journal-title":"Sci Rep"},{"key":"8059_CR17","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrd3669","volume":"11","author":"K Redlich","year":"2012","unstructured":"Redlich K, Smolen JS (2012) Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat Rev Drug Discov 11:234\u2013250","journal-title":"Nat Rev Drug Discov"},{"key":"8059_CR18","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1016\/S0140-6736(17)31491-5","volume":"389","author":"GR Burmester","year":"2017","unstructured":"Burmester GR, Pope JE (2017) Novel treatment strategies in rheumatoid arthritis. Lancet 389:2338\u20132348","journal-title":"Lancet"},{"key":"8059_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9103361","volume":"9","author":"P Fardellone","year":"2020","unstructured":"Fardellone P, Salawati E, Le Monnier L, Go\u00ebb V (2020) Bone loss, osteoporosis, and fractures in patients with rheumatoid arthritis: a review. J Clin Med 9:3361","journal-title":"J Clin Med"},{"key":"8059_CR20","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.jbspin.2019.01.005","volume":"86","author":"F Coutant","year":"2019","unstructured":"Coutant F (2019) Pathogenic effects of anti-citrullinated protein antibodies in rheumatoid arthritis - role for glycosylation. Joint Bone Spine 86:562\u2013567","journal-title":"Joint Bone Spine"},{"key":"8059_CR21","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s00198-020-05360-w","volume":"31","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhao R, Gu Z, Dong C, Guo G, Li L (2020) Effects of glucocorticoids on osteoporosis in rheumatoid arthritis: a systematic review and meta-analysis. Osteoporos Int 31:1401\u20131409","journal-title":"Osteoporos Int"},{"key":"8059_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10061241","author":"Y Tanaka","year":"2021","unstructured":"Tanaka Y (2021) Managing osteoporosis and joint damage in patients with rheumatoid arthritis: an overview. J Clin Med. https:\/\/doi.org\/10.3390\/jcm10061241","journal-title":"J Clin Med"},{"key":"8059_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s12020-018-1588-2","volume":"61","author":"J Compston","year":"2018","unstructured":"Compston J (2018) Glucocorticoid-induced osteoporosis: an update. Endocrine 61:7\u201316","journal-title":"Endocrine"},{"key":"8059_CR24","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1136\/ard.44.9.585","volume":"44","author":"PN Sambrook","year":"1985","unstructured":"Sambrook PN, Abeyasekera G, Ansell BM, Foster S, Gumpel JM, Hill PA, Reeve J, Stevenson JC (1985) Calcium absorption in rheumatoid arthritis. Ann Rheum Dis 44:585\u2013588","journal-title":"Ann Rheum Dis"},{"key":"8059_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20235867","author":"G Adami","year":"2019","unstructured":"Adami G, Fassio A, Rossini M, Caimmi C, Giollo A, Orsolini G, Viapiana O, Gatti D (2019) Osteoporosis in rheumatic diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20235867","journal-title":"Int J Mol Sci"},{"key":"8059_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00198-025-07700-0","volume":"37","author":"T Fu","year":"2026","unstructured":"Fu T, Zhang R, Yue L, Yi X, Cai Y (2026) Risk factors for osteoporosis in rheumatoid arthritis patients: a meta-analysis. Osteoporos Int 37:305\u2013318","journal-title":"Osteoporos Int"},{"key":"8059_CR27","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1097\/JCMA.0000000000001144","volume":"87","author":"Z Song","year":"2024","unstructured":"Song Z, Fan L, Wang H, Cao J, Wen Z, Tao Y, Zhang X (2024) Associated factors of osteoporosis in Chinese patients with rheumatoid arthritis: a systematic review and meta-analysis. J Chin Med Assoc 87:953\u2013960","journal-title":"J Chin Med Assoc"},{"key":"8059_CR28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12891-016-0952-8","volume":"17","author":"JH Lee","year":"2016","unstructured":"Lee JH, Sung YK, Choi CB et al (2016) The frequency of and risk factors for osteoporosis in Korean patients with rheumatoid arthritis. BMC Musculoskelet Disord 17:98","journal-title":"BMC Musculoskelet Disord"},{"key":"8059_CR29","doi-asserted-by":"publisher","first-page":"308","DOI":"10.4314\/ahs.v24i4.39","volume":"24","author":"Y Yang","year":"2024","unstructured":"Yang Y, Chen Y, Zhang L, Yang X, Qiao J (2024) Factors influencing the development of osteoporosis in elderly patients with rheumatoid arthritis. Afr Health Sci 24:308\u2013312","journal-title":"Afr Health Sci"},{"key":"8059_CR30","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s40001-024-02013-0","volume":"29","author":"Z Jiang","year":"2024","unstructured":"Jiang Z, Yao X, Lan W, Ma W, Yao X, Fang T (2024) Association of HDL and LDL levels with osteoporosis in rheumatoid arthritis: a retrospective cohort study. Eur J Med Res 29:439","journal-title":"Eur J Med Res"},{"key":"8059_CR31","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s40200-023-01200-w","volume":"22","author":"A Ketabforoush","year":"2023","unstructured":"Ketabforoush A, Aleahmad M, Qorbani M, Mehrpoor G, Afrashteh S, Mardi S, Dolatshahi E (2023) Bone mineral density status in patients with recent-onset rheumatoid arthritis. J Diabetes Metab Disord 22:775\u2013785","journal-title":"J Diabetes Metab Disord"},{"key":"8059_CR32","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1007\/s10067-022-06212-0","volume":"41","author":"J Qiu","year":"2022","unstructured":"Qiu J, Lu C, Zhang L, Zhou X, Zou H (2022) Osteoporosis in patients with rheumatoid arthritis is associated with serum immune regulatory cellular factors. Clin Rheumatol 41:2685\u20132693","journal-title":"Clin Rheumatol"},{"key":"8059_CR33","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s00774-022-01337-3","volume":"40","author":"J Zou","year":"2022","unstructured":"Zou J, Zhu L, Yang J et al (2022) Correlation between vitamin D metabolites and rheumatoid arthritis with osteoporosis by ultra-high-performance liquid chromatography-tandem mass spectrometry (UPLC-MS\/MS). J Bone Miner Metab 40:696\u2013703","journal-title":"J Bone Miner Metab"},{"key":"8059_CR34","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1080\/00325481.2022.2052626","volume":"135","author":"D Abdelhafiz","year":"2023","unstructured":"Abdelhafiz D, Baker T, Glascow DA, Abdelhafiz A (2023) Biomarkers for the diagnosis and treatment of rheumatoid arthritis - a systematic review. Postgrad Med 135:214\u2013223","journal-title":"Postgrad Med"},{"key":"8059_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.867610","volume":"13","author":"H Huang","year":"2022","unstructured":"Huang H, Wang Y, Xie W, Geng Y, Gao D, Zhang Z (2022) Impact of treat-to-target therapy on bone mineral density loss in patients with rheumatoid arthritis: a prospective cohort study. Front Endocrinol (Lausanne) 13:867610","journal-title":"Front Endocrinol (Lausanne)"},{"key":"8059_CR36","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2147\/IJGM.S506743","volume":"18","author":"B Pei","year":"2025","unstructured":"Pei B, Teng Y, Dong D, Liu L (2025) OPG\/RANK\/RANKL single-nucleotide polymorphisms in rheumatoid arthritis: associations with disease susceptibility, bone mineral density, and clinical manifestations in a Chinese Han population. Int J Gen Med 18:815\u2013824","journal-title":"Int J Gen Med"},{"key":"8059_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-025-01597-9","author":"T Mochizuki","year":"2025","unstructured":"Mochizuki T, Yano K, Otani N, Hiroshima R, Ikari K, Okazaki K (2025) Association between vertebral fractures and comorbidities in patients with rheumatoid arthritis: a cross-sectional study. J Bone Miner Metab. https:\/\/doi.org\/10.1007\/s00774-025-01597-9","journal-title":"J Bone Miner Metab"},{"key":"8059_CR38","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/mr\/roab130","volume":"32","author":"T Furuya","year":"2022","unstructured":"Furuya T (2022) Clinical observations of osteoporosis in Japanese patients with rheumatoid arthritis. Mod Rheumatol 32:839\u2013845","journal-title":"Mod Rheumatol"},{"key":"8059_CR39","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/BOR.0000000000000789","volume":"33","author":"KD Wysham","year":"2021","unstructured":"Wysham KD, Baker JF, Shoback DM (2021) Osteoporosis and fractures in rheumatoid arthritis. Curr Opin Rheumatol 33:270\u2013276","journal-title":"Curr Opin Rheumatol"},{"key":"8059_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2022.101773","volume":"36","author":"R Baker","year":"2022","unstructured":"Baker R, Narla R, Baker JF, Wysham KD (2022) Risk factors for osteoporosis and fractures in rheumatoid arthritis. Best Pract Res Clin Rheumatol 36:101773","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"8059_CR41","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.2147\/IJGM.S349435","volume":"15","author":"L Lian","year":"2022","unstructured":"Lian L, Wang JX, Xu YC, Zong HX, Teng YZ, Xu SQ (2022) Sarcopenia may be a risk factor for osteoporosis in Chinese patients with rheumatoid arthritis. Int J Gen Med 15:2075\u20132085","journal-title":"Int J Gen Med"},{"key":"8059_CR42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40001-024-01665-2","volume":"29","author":"YR Chu","year":"2024","unstructured":"Chu YR, Xu YC, Ma LL, Wang JX, Zong HX, Tong WQ, Wang XL, Zhao X, Xu SQ (2024) Skeletal muscle index together with body mass index is associated with secondary osteoporosis in patients with rheumatoid arthritis. Eur J Med Res 29:61","journal-title":"Eur J Med Res"},{"key":"8059_CR43","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1136\/annrheumdis-2022-222339","volume":"81","author":"E Wiebe","year":"2022","unstructured":"Wiebe E, Huscher D, Schaumburg D et al (2022) Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease. Ann Rheum Dis 81:1313\u20131322","journal-title":"Ann Rheum Dis"},{"key":"8059_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2022.101757","volume":"36","author":"KD Wysham","year":"2022","unstructured":"Wysham KD, Baker JF, Narla R (2022) Osteoporosis and fractures in rheumatoid arthritis - risk factors. Best Pract Res Clin Rheumatol 36:101757","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"8059_CR45","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13075-023-03083-x","volume":"25","author":"A Palmowski","year":"2023","unstructured":"Palmowski A, Boyadzhieva Z, Nielsen SM, Muche B, Hermann S, Boers M, Bliddal H, Christensen R, Wiebe E, Buttgereit F (2023) Sex and age do not modify the association between glucocorticoids and bone mineral density in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther 25:98","journal-title":"Arthritis Res Ther"},{"key":"8059_CR46","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00296-008-0682-9","volume":"29","author":"A Pfeil","year":"2009","unstructured":"Pfeil A, Lippold J, Eidner T et al (2009) Effects of leflunomide and methotrexate in rheumatoid arthritis detected by digital X-ray radiogrammetry and computer-aided joint space analysis. Rheumatol Int 29:287\u2013295","journal-title":"Rheumatol Int"},{"key":"8059_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2023.100726","volume":"99","author":"DP Destiani","year":"2023","unstructured":"Destiani DP, Utami VM, Farhanah S, Alfian SD, Dewi S, Sulaiman SAS, Abdulah R (2023) Methotrexate increases serum calcium levels in patients with rheumatoid arthritis: a retrospective study at a referral hospital in Indonesia. Curr Ther Res Clin Exp 99:100726","journal-title":"Curr Ther Res Clin Exp"},{"key":"8059_CR48","first-page":"137","volume":"23","author":"O Di Munno","year":"2005","unstructured":"Di Munno O, Delle Sedie A, Rossini M, Adami S (2005) Disease-modifying antirheumatic drugs and bone mass in rheumatoid arthritis. Clin Exp Rheumatol 23:137\u2013144","journal-title":"Clin Exp Rheumatol"},{"key":"8059_CR49","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2024-004886","author":"Y Teng","year":"2024","unstructured":"Teng Y, Yin H, Feng R, Jiang L, Qiu W, Duan X, Wang X, Deng GM (2024) Methotrexate inhibits glucocorticoids-induced osteoclastogenesis via activating IFN-\u03b3R\/STAT1 pathway in the treatment of rheumatoid arthritis. RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2024-004886","journal-title":"RMD Open"},{"key":"8059_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58070852","author":"BW Song","year":"2022","unstructured":"Song BW, Kim AR, Moon DH, Kim YK, Kim GT, Ahn EY, So MW, Lee SG (2022) Associations of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and monocyte-to-lymphocyte ratio with osteoporosis and incident vertebral fracture in postmenopausal women with rheumatoid arthritis: a single-center retrospective cohort study. Medicina (Kaunas). https:\/\/doi.org\/10.3390\/medicina58070852","journal-title":"Medicina (Kaunas)"},{"key":"8059_CR51","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1007\/s10067-023-06725-2","volume":"42","author":"X Gong","year":"2023","unstructured":"Gong X, Tang Y, Yu SS, Shi W, Wang YR, Deng JL, Rui JB, Qiu YY (2023) Elevated serum leptin may be associated with disease activity and secondary osteoporosis in Chinese patients with rheumatoid arthritis. Clin Rheumatol 42:3333\u20133340","journal-title":"Clin Rheumatol"},{"key":"8059_CR52","doi-asserted-by":"publisher","first-page":"384","DOI":"10.5114\/reum.2022.123669","volume":"60","author":"Y Adel","year":"2022","unstructured":"Adel Y, Sadeq Y (2022) 14-3-3\u03b7 protein is associated with disease activity and osteoporosis in patients with rheumatoid arthritis. Reumatologia 60:384\u2013391","journal-title":"Reumatologia"},{"key":"8059_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-021-04403-5","volume":"22","author":"Z Hu","year":"2021","unstructured":"Hu Z, Zhang L, Lin Z, Zhao C, Xu S, Lin H, Zhang J, Li W, Chu Y (2021) Prevalence and risk factors for bone loss in rheumatoid arthritis patients from South China: modeled by three methods. BMC Musculoskelet Disord 22:534","journal-title":"BMC Musculoskelet Disord"},{"key":"8059_CR54","doi-asserted-by":"publisher","first-page":"222","DOI":"10.4103\/ajim.ajim_89_22","volume":"11","author":"V Sood","year":"2023","unstructured":"Sood V, Sharma M, Chauhan P, Dogra PM, Kumar A, Subramanian S (2023) Association of hypovitaminosis D with poor bone health in patients of rheumatoid arthritis \u2013 a case\u2013control study. APIK J Intern Med 11:222\u2013227","journal-title":"APIK J Intern Med"},{"key":"8059_CR55","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1590\/S1516-31802009000400007","volume":"127","author":"KS Sarkis","year":"2009","unstructured":"Sarkis KS, Salvador MB, Pinheiro MM, Silva RG, Zerbini CA, Martini LA (2009) Association between osteoporosis and rheumatoid arthritis in women: a cross-sectional study. Sao Paulo Med J 127:216\u2013222","journal-title":"Sao Paulo Med J"},{"key":"8059_CR56","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1007\/s11606-016-3645-y","volume":"31","author":"GM Allan","year":"2016","unstructured":"Allan GM, Cranston L, Lindblad A, McCormack J, Kolber MR, Garrison S, Korownyk C (2016) Vitamin D: a narrative review examining the evidence for ten beliefs. J Gen Intern Med 31:780\u2013791","journal-title":"J Gen Intern Med"},{"key":"8059_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-024-07768-5","volume":"25","author":"D Fang","year":"2024","unstructured":"Fang D, Jiang D, Shi G, Song Y (2024) The association between dietary zinc intake and osteopenia, osteoporosis in patients with rheumatoid arthritis. BMC Musculoskelet Disord 25:710","journal-title":"BMC Musculoskelet Disord"},{"key":"8059_CR58","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.jos.2021.08.018","volume":"27","author":"Y Nagayama","year":"2022","unstructured":"Nagayama Y, Ebina K, Tsuboi H, Hirao M, Hashimoto J, Yoshikawa H, Okada S, Nakata K (2022) Low serum albumin concentration is associated with increased risk of osteoporosis in postmenopausal patients with rheumatoid arthritis. J Orthop Sci 27:1283\u20131290","journal-title":"J Orthop Sci"},{"key":"8059_CR59","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-020-00815-3","volume":"15","author":"R Peterkin-McCalman","year":"2020","unstructured":"Peterkin-McCalman R, Waller JL, Le B, Oliver AM, Manning E, Elam RE, Kheda M, Nahman NS Jr., Carbone LD (2020) Fractures in patients with rheumatoid arthritis and end-stage renal disease. Arch Osteoporos 15:146","journal-title":"Arch Osteoporos"},{"key":"8059_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2023.116958","volume":"179","author":"G Adami","year":"2024","unstructured":"Adami G, Gatti D, Rossini M et al (2024) Risk of fracture in women with glucocorticoid requiring diseases is independent from glucocorticoid use: an analysis on a nation-wide database. Bone 179:116958","journal-title":"Bone"},{"key":"8059_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14030795","author":"Y Kim","year":"2025","unstructured":"Kim Y, Kwon OC, Kim R et al (2025) Association of immune-mediated inflammatory diseases and fracture risk in patients with type 2 diabetes: a nationwide population-based study. J Clin Med. https:\/\/doi.org\/10.3390\/jcm14030795","journal-title":"J Clin Med"},{"key":"8059_CR62","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1007\/s00198-023-06870-z","volume":"34","author":"JA Kanis","year":"2023","unstructured":"Kanis JA, Johansson H, McCloskey EV et al (2023) Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX. Osteoporos Int 34:2027\u20132045","journal-title":"Osteoporos Int"},{"key":"8059_CR63","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1007\/s10067-021-05998-9","volume":"41","author":"R Sghiri","year":"2022","unstructured":"Sghiri R, Benhassine H, Baccouche K et al (2022) A CD40 variant is associated with systemic bone loss among patients with rheumatoid arthritis. Clin Rheumatol 41:1851\u20131858","journal-title":"Clin Rheumatol"},{"key":"8059_CR64","unstructured":"Elam R, Li J, Paul A, Kersey E, Schmajuk g, Leslie W, Carbone L (2025) Assessing for racial\/ethnic variability in U.S.-FRAXTM performance among older adult women with rheumatoid arthritis in the United States [abstract]. Arthritis Rheumatol 77 (suppl 9). https:\/\/acrabstracts.org\/abstract\/assessing-for-racial-ethnic-variability-in-u-s-fraxtm-performance-among-older-adult-women-with-rheumatoid-arthritis-in-the-united-states"},{"key":"8059_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2022.151972","volume":"53","author":"KD Wysham","year":"2022","unstructured":"Wysham KD, Shofer J, Lui G, Trupin L, Andrews JS, Black DM, Graf J, Shoback DM, Katz PP (2022) Low cumulative disease activity is associated with higher bone mineral density in a majority Latinx and Asian US rheumatoid arthritis cohort. Semin Arthritis Rheum 53:151972","journal-title":"Semin Arthritis Rheum"},{"key":"8059_CR66","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1093\/rheumatology\/keu162","volume":"53","author":"B Hauser","year":"2014","unstructured":"Hauser B, Riches PL, Wilson JF, Horne AE, Ralston SH (2014) Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis. Rheumatology (Oxford) 53:1759\u20131766","journal-title":"Rheumatology (Oxford)"},{"key":"8059_CR67","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1136\/ard.59.10.805","volume":"59","author":"TK Kvien","year":"2000","unstructured":"Kvien TK, Haugeberg G, Uhlig T, Falch JA, Halse JI, Lems WF, Dijkmans BA, Woolf AD (2000) Data driven attempt to create a clinical algorithm for identification of women with rheumatoid arthritis at high risk of osteoporosis. Ann Rheum Dis 59:805\u2013811","journal-title":"Ann Rheum Dis"},{"key":"8059_CR68","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-020-00867-5","volume":"16","author":"X Yan","year":"2021","unstructured":"Yan X, Xu Z, Li S, Yan L, Lyu G, Wang Z (2021) Establishment and verification of an osteoporosis risk model in patients with rheumatoid arthritis: a valuable new model. Arch Osteoporos 16:3","journal-title":"Arch Osteoporos"},{"key":"8059_CR69","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.15358","volume":"27","author":"R Saito","year":"2024","unstructured":"Saito R, Fujii T, Murata K, Onishi A, Murakami K, Tanaka M, Ohmura K, Yasuda T, Morinobu A, Matsuda S (2024) Prediction models incorporating second metacarpal cortical index for osteoporosis in rheumatoid arthritis: externally validated machine learning models developed using data from the KURAMA cohort. Int J Rheum Dis 27:e15358","journal-title":"Int J Rheum Dis"},{"key":"8059_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-025-03544-5","volume":"27","author":"Y Shao","year":"2025","unstructured":"Shao Y, Yang Y, Yang X et al (2025) A diagnostic model for assessing the risk of osteoporosis in patients with rheumatoid arthritis based on bone turnover markers. Arthritis Res Ther 27:75","journal-title":"Arthritis Res Ther"},{"key":"8059_CR71","doi-asserted-by":"publisher","first-page":"7817","DOI":"10.2147\/IJGM.S380197","volume":"15","author":"R Chen","year":"2022","unstructured":"Chen R, Huang Q, Chen L (2022) Development and validation of machine learning models for prediction of fracture risk in patients with elderly-onset rheumatoid arthritis. Int J Gen Med 15:7817\u20137829","journal-title":"Int J Gen Med"},{"key":"8059_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-48842-7","volume":"13","author":"C Lee","year":"2023","unstructured":"Lee C, Joo G, Shin S, Im H, Moon KW (2023) Prediction of osteoporosis in patients with rheumatoid arthritis using machine learning. Sci Rep 13:21800","journal-title":"Sci Rep"},{"key":"8059_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2024.0341","volume":"85","author":"F Kirkham-Wilson","year":"2024","unstructured":"Kirkham-Wilson F, Dennison E (2024) Osteoporosis and rheumatoid arthritis: a review of current understanding and practice. Br J Hosp Med (Lond) 85:1\u201311","journal-title":"Br J Hosp Med (Lond)"},{"key":"8059_CR74","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s10067-024-06932-5","volume":"43","author":"N Gupta","year":"2024","unstructured":"Gupta N, Kanwar N, Arora A, Khatri K, Kanwal A (2024) The interplay of rheumatoid arthritis and osteoporosis: exploring the pathogenesis and pharmacological approaches. Clin Rheumatol 43:1421\u20131433","journal-title":"Clin Rheumatol"},{"key":"8059_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/ar3025","volume":"12","author":"M G\u00fcler-Y\u00fcksel","year":"2010","unstructured":"G\u00fcler-Y\u00fcksel M, Klarenbeek NB, Goekoop-Ruiterman YP et al (2010) Accelerated hand bone mineral density loss is associated with progressive joint damage in hands and feet in recent-onset rheumatoid arthritis. Arthritis Res Ther 12:R96","journal-title":"Arthritis Res Ther"},{"key":"8059_CR76","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","volume":"19","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAX\u2122 and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19:385\u2013397","journal-title":"Osteoporos Int"},{"key":"8059_CR77","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-025-07397-1","author":"JA Kanis","year":"2025","unstructured":"Kanis JA, Johansson H, McCloskey EV et al (2025) Rheumatoid arthritis and subsequent fracture risk: an individual person meta-analysis to update FRAX. Osteoporos Int. https:\/\/doi.org\/10.1007\/s00198-025-07397-1","journal-title":"Osteoporos Int"},{"key":"8059_CR78","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/rheumatology\/kead676","volume":"64","author":"C Richards","year":"2025","unstructured":"Richards C, Stevens R, Lix LM, McCloskey EV, Johansson H, Harvey NC, Kanis JA, Leslie WD (2025) Fracture prediction in rheumatoid arthritis: validation of FRAX with bone mineral density for incident major osteoporotic fractures. Rheumatology (Oxford) 64:228\u2013234","journal-title":"Rheumatology (Oxford)"},{"key":"8059_CR79","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3899\/jrheum.2022-1293","volume":"50","author":"J Mousa","year":"2023","unstructured":"Mousa J, Peterson MN, Crowson CS, Achenbach SJ, Atkinson EJ, Amin S, Khosla S, Davis JM 3rd, Myasoedova E (2023) Validating the fracture risk assessment tool score in a US population-based study of patients with rheumatoid arthritis. J Rheumatol 50:1279\u20131286","journal-title":"J Rheumatol"},{"key":"8059_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2024.101806","volume":"23","author":"H Boutaibi","year":"2024","unstructured":"Boutaibi H, Azzouzi H, Chennouf F, Ichchou L (2024) Association between trabecular bone score, 10-year probability risk for fracture, and vertebral fractures in rheumatoid arthritis. Bone Rep 23:101806","journal-title":"Bone Rep"},{"key":"8059_CR81","doi-asserted-by":"publisher","DOI":"10.1177\/20406223221078089","volume":"13","author":"SF Yu","year":"2022","unstructured":"Yu SF, Chen MH, Chen JF et al (2022) Establishment of a preliminary FRAX\u00ae-based intervention threshold for rheumatoid arthritis-associated fragility fracture: a 3-year longitudinal, observational, cohort study. Ther Adv Chronic Dis 13:20406223221078089","journal-title":"Ther Adv Chronic Dis"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-08059-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-026-08059-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-08059-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:07:23Z","timestamp":1792271243000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-026-08059-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":81,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["8059"],"URL":"https:\/\/doi.org\/10.1007\/s00198-026-08059-6","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"4 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}